Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2020 Q1- Text added to 2020 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
belief, bladder, buildout, Catapult, commercialisation, commercialise, conclusion, durability, EGJ, esophagogastric, gastroesophageal, junction, MHRA, mucosal, pembrolizumab, rectal, understanding, underway, utilising, workforce
Removed:
activation, CRO, dendritic, director, excluding, expansion, fourth, nominate, RECIST, satisfying, UK
Valuein 2020 Q1 filing- Value in 2020 Q2 filing
Original filings
Filing view